We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-1.88%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$3.73B
AUM Growth
-$641M
Cap. Flow
-$442M
Cap. Flow %
-11.83%
Top 10 Hldgs %
5.17%
Holding
1,489
New
168
Increased
277
Reduced
362
Closed
84

Top Sells

Rank Stock Value
1
LHX icon
L3Harris
LHX
+$18.8M
2
WAT icon
Waters Corp
WAT
+$15.6M
3
CMI icon
Cummins
CMI
+$15.3M
4
CI icon
Cigna
CI
+$15.1M
5
AMP icon
Ameriprise Financial
AMP
+$13.2M

Sector Composition

Rank Sector Weight
1 Financials 27.38%
2 Energy 11.53%
3 Industrials 10.56%
4 Consumer Discretionary 10.28%
5 Technology 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USIO icon
1301
Usio Inc
USIO
$64M
$86K ﹤0.01%
66,400
-70,000
-51% -$128K
EARN
1302
Ellington Residential Mortgage REIT
EARN
$165M
$85K ﹤0.01%
+13,800
New +$110K
ZYNE
1303
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$85K ﹤0.01%
115,900
-50,000
-30% -$56.7K
RNWK
1304
DELISTED
RealNetworks Inc
RNWK
$85K ﹤0.01%
121,900
-95,000
-44% -$62.9K
JVA icon
1305
Coffee Holding Co
JVA
$20M
$83K ﹤0.01%
33,000
XTNT icon
1306
Xtant Medical Holdings
XTNT
$62.3M
$82K ﹤0.01%
114,500
-232,500
-67% -$127K
SPRB
1307
Spruce Biosciences
SPRB
$129M
$82K ﹤0.01%
800
BFX
1308
DELISTED
BowFlex Inc.
BFX
$82K ﹤0.01%
50,000
AYLA
1309
DELISTED
Ayala Pharmaceuticals, Inc. Common Stock
AYLA
$82K ﹤0.01%
81,900
PLUR icon
1310
Pluri
PLUR
$19.6M
$80K ﹤0.01%
12,825
-1,250
-9% -$9.98K
WVVI icon
1311
Willamette Valley Vineyards
WVVI
$11.9M
$80K ﹤0.01%
13,000
GLS
1312
DELISTED
Gelesis Holdings, Inc.
GLS
$80K ﹤0.01%
74,300
+48,300
+186% +$63.9K
MIND icon
1313
MIND Technology
MIND
$46.2M
$79K ﹤0.01%
12,332
TKAT
1314
DELISTED
Takung Art Co., Ltd.
TKAT
$79K ﹤0.01%
76,000
LCI
1315
DELISTED
Lannett Company, Inc.
LCI
$78K ﹤0.01%
43,300
MRIN
1316
DELISTED
Marin Software
MRIN
$77K ﹤0.01%
10,000
SGTX
1317
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$76K ﹤0.01%
11,538
FSRD
1318
DELISTED
Fast Radius, Inc. Class A Common Stock
FSRD
$76K ﹤0.01%
190,000
-25,000
-12% -$15.2K
IMBI
1319
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$73K ﹤0.01%
113,617
-20,500
-15% -$24.3K
ALR
1320
DELISTED
AlerisLife Inc
ALR
$73K ﹤0.01%
77,100
-37,700
-33% -$43.3K
UAMY icon
1321
United States Antimony
UAMY
$1.02B
$72K ﹤0.01%
195,500
-50,000
-20% -$21.8K
VRCA icon
1322
Verrica Pharmaceuticals
VRCA
$87.3M
$72K ﹤0.01%
2,455
SIEN
1323
DELISTED
Sientra, Inc.
SIEN
$72K ﹤0.01%
11,300
LFLY
1324
DELISTED
Leafly Holdings, Inc. Common Stock
LFLY
$71K ﹤0.01%
+5,195
New +$289K
AFIB
1325
DELISTED
Acutus Medical Inc
AFIB
$70K ﹤0.01%
+79,500
New +$96.2K

Similar funds

Bridgeway Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Bridgeway Capital Management held 1,489 positions worth $3.73B, down 15% from $4.38B the previous quarter. Its ten largest holdings account for 5.2% of the portfolio.

Bridgeway Capital Management withdrew a net $442M in Q3 2022, closing 84 positions and reducing 362 holdings. Its most notable exit was L3Harris, an estimated $18.8M position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 27% a quarter earlier, followed by Energy and Industrials.

Against the trend, Bridgeway Capital Management opened a new position in Cleveland-Cliffs worth $11M.

  • Bridgeway Capital Management's largest Q3 2022 buy was Cleveland-Cliffs: 819,000 shares worth $11M.
  • Bridgeway Capital Management added most to Meta Platforms (Facebook) in Q3 2022, an estimated $13.9M increase.
  • Bridgeway Capital Management's biggest Q3 2022 reduction was Waters Corp, cutting an estimated $15.6M.
  • Bridgeway Capital Management fully exited L3Harris in Q3 2022, selling an estimated $18.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.2% of its $3.73B portfolio in Q3 2022.
  • Bridgeway Capital Management opened 168 new positions and closed 84 in Q3 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $3.73B.

Based on Bridgeway Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.